News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,294 Results
Type
Article (40033)
Company Profile (251)
Press Release (665009)
Multimedia
Podcasts (58)
Webinars (14)
Section
Business (204413)
Career Advice (2011)
Deals (35474)
Drug Delivery (95)
Drug Development (81143)
Employer Resources (172)
FDA (16252)
Job Trends (14887)
News (345664)
Policy (32614)
Tag
Academia (2558)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49637)
ALS (108)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (151)
Approvals (16248)
Artificial intelligence (308)
Autoimmune disease (28)
Automation (18)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (121)
Biotechnology (175)
Bladder cancer (93)
Brain cancer (33)
Breast cancer (364)
Cancer (2856)
Cardiovascular disease (211)
Career advice (1681)
Career pathing (30)
CAR-T (185)
CDC (30)
Cell therapy (497)
Cervical cancer (22)
Clinical research (66847)
Collaboration (1011)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2624)
CRISPR (56)
C-suite (323)
Cystic fibrosis (112)
Data (2989)
Decentralized trials (2)
Denatured (20)
Depression (60)
Diabetes (346)
Diagnostics (6427)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (121)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87460)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (113792)
Executive appointments (845)
FDA (17893)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (928)
Gene editing (129)
Generative AI (22)
Gene therapy (372)
GLP-1 (780)
Government (4501)
Grass and pollen (4)
Guidances (181)
Healthcare (18839)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (146)
Immuno-oncology (8)
Indications (39)
Infectious disease (2795)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (119)
Interviews (312)
IPO (16592)
IRA (44)
Job creations (3637)
Job search strategy (1424)
Kidney cancer (13)
Labor market (52)
Layoffs (491)
Leadership (18)
Legal (7931)
Liver cancer (79)
Lung cancer (399)
Lymphoma (208)
Machine learning (11)
Management (58)
Manufacturing (384)
MASH (90)
Medical device (13460)
Medtech (13465)
Mergers & acquisitions (19595)
Metabolic disorders (846)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (113)
Neuropsychiatric disorders (31)
Neuroscience (2113)
NextGen: Class of 2025 (6520)
Non-profit (4488)
Now hiring (47)
Obesity (426)
Opinion (218)
Ovarian cancer (101)
Pain (105)
Pancreatic cancer (120)
Parkinson's disease (186)
Partnered (22)
Patents (296)
Patient recruitment (163)
Peanut (50)
People (57725)
Pharmaceutical (64)
Pharmacy benefit managers (21)
Phase I (20829)
Phase II (29443)
Phase III (21915)
Pipeline (1626)
Policy (198)
Postmarket research (2563)
Preclinical (8870)
Press Release (64)
Prostate cancer (139)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (457)
Real estate (5921)
Recruiting (66)
Regulatory (22631)
Reports (50)
Research institute (2327)
Resumes & cover letters (350)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (156)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3592)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (57)
The Weekly (36)
Vaccines (778)
Venture capital (53)
Weight loss (255)
Women's health (47)
Worklife (16)
Date
Today (71)
Last 7 days (371)
Last 30 days (1860)
Last 365 days (31257)
2025 (16708)
2024 (35222)
2023 (40084)
2022 (51179)
2021 (55718)
2020 (54091)
2019 (46553)
2018 (35020)
2017 (32122)
2016 (31492)
2015 (37569)
2014 (31344)
2013 (26375)
2012 (28599)
2011 (29290)
2010 (27359)
Location
Africa (720)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38222)
Australia (6236)
California (7427)
Canada (2355)
China (669)
Colorado (320)
Connecticut (318)
Delaware (192)
Europe (82199)
Florida (1115)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (636)
India (26)
Indiana (361)
Iowa (16)
Japan (227)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1019)
Massachusetts (5515)
Michigan (246)
Minnesota (449)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2070)
New Mexico (28)
New York (2082)
North Carolina (1078)
North Dakota (8)
Northern California (3269)
Ohio (235)
Oklahoma (16)
Oregon (34)
Pennsylvania (1609)
Puerto Rico (17)
Rhode Island (36)
South America (1100)
South Carolina (34)
South Dakota (1)
Southern California (2777)
Tennessee (126)
Texas (1119)
United States (27508)
Utah (219)
Virginia (184)
Washington D.C. (72)
Washington State (630)
West Virginia (4)
Wisconsin (66)
705,294 Results for "perseptive biosystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025
July 14, 2025
·
4 min read
Press Releases
Trailhead Biosystems Announces David Llewellyn, PhD, MBA, as Chief Executive Officer
May 20, 2025
·
2 min read
Press Releases
Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
May 27, 2025
·
5 min read
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
May 12, 2025
·
9 min read
Press Releases
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
December 16, 2024
·
4 min read
Press Releases
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
2 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau.
June 25, 2024
·
4 min read
Genetown
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of an additional $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity.
May 6, 2024
·
4 min read
Genetown
T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, announced the execution of a territory exclusive distribution agreement in Qatar.
May 6, 2024
·
5 min read
Press Releases
Rapid Micro Biosystems to Participate in Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
1 of 70,530
Next
